Liangnian Ji Selected Research

Iridium

1/2022	Photodecaging of a Mitochondria-Localized Iridium(III) Endoperoxide Complex for Two-Photon Photoactivated Therapy under Hypoxia.
8/2021	Iridium(iii) complexes as mitochondrial topoisomerase inhibitors against cisplatin-resistant cancer cells.
1/2021	An ER-Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non-Small-Cell Lung Cancer.
1/2021	Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy.
1/2020	FerriIridium: A Lysosome-Targeting Iron(III)-Activated Iridium(III) Prodrug for Chemotherapy in Gastric Cancer Cells.
7/2017	Two-photon photodynamic ablation of tumor cells by mitochondria-targeted iridium(iii) complexes in aggregate states.
6/2016	Iridium(III) Anthraquinone Complexes as Two-Photon Phosphorescence Probes for Mitochondria Imaging and Tracking under Hypoxia.
10/2015	Azo-Based Iridium(III) Complexes as Multicolor Phosphorescent Probes to Detect Hypoxia in 3D Multicellular Tumor Spheroids.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liangnian Ji Research Topics

Disease

51	Neoplasms (Cancer) 11/2022 - 11/2010
8	Hypoxia (Hypoxemia) 01/2022 - 01/2015
4	Phototoxic Dermatitis (Phototoxicity) 01/2022 - 11/2015
3	Triple Negative Breast Neoplasms 10/2021 - 01/2021
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 03/2013
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Pathologic Processes 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2016 - 09/2011
1	Colonic Neoplasms (Colon Cancer) 08/2021
1	Melanoma (Melanoma, Malignant) 02/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 07/2020
1	Hyperthermia 04/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Necrosis 06/2018
1	Poisoning 06/2016
1	Liver Neoplasms (Liver Cancer) 02/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2008
1	Leukemia 02/2008

Drug/Important Bio-Agent (IBA)

17	RutheniumIBA 05/2021 - 11/2010
12	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 11/2010
12	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022 - 10/2015
8	Pharmaceutical PreparationsIBA 11/2022 - 01/2015
8	IridiumIBA 01/2022 - 10/2015
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2014
5	Photosensitizing Agents (Photosensitizers)IBA 05/2021 - 06/2017
4	Glutathione (Reduced Glutathione)IBA 11/2022 - 01/2021
4	Singlet OxygenIBA 01/2022 - 06/2019
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 09/2011
3	Biotin (Vitamin H)FDA Link 01/2022 - 09/2019
3	Oxygen (Dioxygen)IBA 01/2022 - 11/2020
3	AnthraquinonesIBA 06/2016 - 01/2015
2	PolymersIBA 11/2022 - 01/2022
2	ProdrugsIBA 01/2022 - 01/2020
2	4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA 10/2021 - 02/2021
2	Peroxynitrous Acid (Peroxynitrite)IBA 01/2021 - 01/2020
2	IronIBA 01/2021 - 01/2020
2	MetalsIBA 01/2019 - 01/2016
2	GoldIBA 01/2017 - 09/2015
2	PhenanthrolinesIBA 06/2016 - 01/2016
2	Oxidoreductases (Dehydrogenase)IBA 06/2016 - 10/2015
2	LigandsIBA 11/2010 - 02/2008
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022
1	Topoisomerase InhibitorsIBA 08/2021
1	ApoferritinsIBA 08/2021
1	Hyaluronic Acid (Hyaluronan)IBA 04/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	Adenosine Triphosphate (ATP)IBA 01/2021
1	TitaniumIBA 01/2021
1	graphitic carbon nitrideIBA 01/2021
1	CalreticulinIBA 01/2021
1	CarbonIBA 11/2020
1	FluorineIBA 06/2020
1	Glucose (Dextrose)FDA LinkGeneric 05/2020
1	manganese ferriteIBA 04/2020
1	mahuang-tangIBA 04/2020
1	Superoxides (Superoxide)IBA 01/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020
1	trioctyl phosphine oxide (TOPO)IBA 01/2020
1	AnionsIBA 01/2020
1	morpholineIBA 09/2019
1	PlatinumIBA 09/2019
1	HydrogelsIBA 01/2019
1	AlbuminsIBA 01/2019
1	LipopolysaccharidesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 06/2018
1	CalpainIBA 06/2018
1	Antineoplastic Agents (Antineoplastics)IBA 02/2017
1	Annexin A5IBA 08/2016
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 08/2016
1	hydroquinone (Esoterica)FDA Link 06/2016
1	quinone (benzoquinone)IBA 06/2016
1	Thioredoxin-Disulfide ReductaseIBA 01/2016
1	Small Interfering RNA (siRNA)IBA 01/2016
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2015
1	Transcription Factors (Transcription Factor)IBA 11/2014
1	EnzymesIBA 06/2013
1	tau Proteins (tau Protein)IBA 03/2013
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 05/2011
1	imidazolium- bis(imidazole)dimethylsulfoxideimidazotetrachlororuthenate(III) (NAMI-A)IBA 05/2011
1	imidazoleIBA 05/2011
1	Carbolines (Beta-Carbolines)IBA 11/2010
1	AlkaloidsIBA 11/2010

Therapy/Procedure

17	Therapeutics 11/2022 - 11/2010
14	Photochemotherapy (Photodynamic Therapy) 11/2022 - 07/2015
8	Drug Therapy (Chemotherapy) 01/2022 - 01/2015
4	Photothermal Therapy 01/2020 - 10/2015
2	Semiconductor Lasers 10/2015 - 09/2015
2	Radiotherapy 10/2015 - 01/2015
1	Aftercare (After-Treatment) 01/2021
1	Precision Medicine 01/2020
1	Lasers (Laser) 06/2017
1	Quantum Dots (Quantum Dot) 01/2016
1	Combined Modality Therapy 10/2015
1	Nanospheres 09/2015